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Abstract
Background—Individuals with a strong family history of colorectal cancer (CRC) have
significant risk for CRC, though adherence to colonoscopy screening in these groups remains low.
This study assessed whether a tailored, telephone counseling intervention can increase adherence
to colonoscopy in members of high risk families in a randomized, controlled trial.
Methods—Eligible participants were recruited from two national cancer registries if they had a
first-degree relative with CRC under age 60 or multiple affected family members, which included
families that met Amsterdam criteria for Hereditary Non-Polyposis Colon Cancer, and if they
were due for colonoscopy within 24-months. Participants were randomized to receive a tailored,
telephone intervention grounded in behavioral theory or a mailed packet with general information
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about screening. Colonoscopy status was assessed through follow-up surveys and endoscopy
reports. Cox-proportional hazards models were used to assess intervention effect.
Results—Of the 632 participants (aged 25–80), 60% were female, the majority were White, non-
Hispanic, educated and had health insurance. Colonoscopy adherence increased 11 percentage
points in the tailored, telephone intervention group, compared to no significant change in the
mailed group. The telephone intervention was associated with a 32% increase in screening
adherence compared to the mailed intervention (Hazard Ratio=1.32; p=0.01).
Conclusions—A tailored, telephone intervention can effectively increase colonoscopy
adherence in high risk persons. This intervention has the potential for broad dissemination to
health-care organizations or other high risk populations.
Impact—Increasing adherence to colonoscopy among persons with increased CRC risk could
effectively reduce incidence and mortality from this disease.
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Introduction
Though widely considered preventable, colorectal cancer (CRC) remains a common and
often fatal cancer. More than 140,000 men and women in the U.S. will develop CRC each
year, and 50,000 will die from this disease [1]. The lifetime risk for developing CRC is
about five percent but a family history of CRC substantially increases this risk; having a first
degree relative with CRC increases the risk about two-fold but if the relative has CRC under
age 60 or there is more than a single first-degree relative the risk increases three to six fold
[2–4]. Moreover, the risk for developing CRC for members of families with genetic
predisposition to CRC, specifically Lynch Syndrome, is approximately nine times higher
than general population risk [5–8].
A family history of CRC also has a major influence on recommendations for CRC
screening. For average risk populations without a family history of CRC, screening is
recommended to begin at age 50 with any of several screening tests (annual stool tests,
sigmoidoscopy every five years with or without a stool test, or colonoscopy every 10 years)
[9,10]. Surveillance increases with family history of CRC. It is currently recommended that
first-degree relatives of patients with CRC under age 60 be screened with colonoscopy
starting at age 40 or 10 years prior to the earliest CRC diagnosis in the family no less than
every five years [9,10]. Because of their markedly increased CRC risk, members of families
with Lynch Syndrome are advised to have colonoscopy screening every one to two years
starting at age 20–25 or two to five years prior to the earliest CRC if it is diagnosed before
age 25 [10]. About three to five percent of the population is thought to fall into one of these
high risk groups [3,11] but they represent a disproportionate number of incident CRC and
CRC deaths, which magnifies the importance of screening adherence in these families.
Despite the established efficacy of endoscopy screening to reduce CRC incidence and
mortality [12–15], adherence to CRC screening remains suboptimal even in these high risk
groups [16–20]. The Family Health Promotion Project (FHPP) was a randomized, controlled
trial to test the effectiveness of a telephone-based, counseling intervention to increase
adherence to colonoscopy screening in members of high risk CRC families. The study
design and results from the baseline survey have been described previously [17]. We report
here the primary outcome data for FHPP; the effect of the intervention on colonoscopy
screening adherence.
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The FHPP was a multi-center, randomized, controlled trial. Participants at increased for
CRC as described below were recruited from two national cancer family registries, the
Colon Cancer Family Registry (C-CFR) and the Cancer Genetics Network (CGN) between
February 2005 and July 2006 [21–22]. Consenting participants completed a baseline survey
and were randomized to receive either a tailored, one time telephone-based counseling
intervention (tailored telephone intervention) or a mailed packet. Participants were mailed
follow-up assessments at 6, 12, and 24 months to assess screening behavior as well as
participants’ knowledge, attitudes and beliefs about CRC screening and barriers to having
screening (ex. cost, no symptoms, busy, fear/anxiety about the test, worry about the prep)
[17]. Questions on the baseline and follow up surveys were adapted and validated from
previous studies [17, 23–25]. The primary outcome for the study was prevalence of
colonoscopy screening in the two groups within the 24-month study period from
randomization. This study was approved by the Colorado Multiple Institutional Review
Board (IRB #03-858).
Participants
Participants were recruited from eight C-CFR and three CGN registry sites; CGN centers:
Universities of Utah (n=61), New Mexico (n=4) and Colorado (n=51); C-CFR centers:
Universities of Arizona (n=25), North Carolina (n=16), Minnesota (n=56), Southern
California (n=5) and Colorado (n=38), the Cleveland Clinic (n=95), Mayo Clinic (n=95) and
The Fred Hutchinson Cancer Research Center (n=185). Eligible participants were unaffected
with CRC, at least 21 years of age, English speaking and at increased risk for CRC on the
basis of their family history. Two classes of increased risk were defined. Participants from
families that met the Amsterdam II criteria for hereditary non-polyposis colorectal cancer
(HNPCC): three biological relatives with CRC or other HNPCC-associated cancers with one
being a first degree relative of the other two and at least two generations affected, and one
cancer diagnosis under 50 years of age [7], were classified as ‘HNPCC’ participants. We
used the term HNPCC for these participants because genetic testing had not been confirmed
for these families and the term Lynch Syndrome is typically reserved for families with
confirmed mutations in a DNA mismatch repair gene. Participants that had at least one first-
degree relative diagnosed with CRC under age 60 or two or more first-degree relatives
diagnosed with CRC at any age were defined as ‘High Risk’. Eligible participants must have
been due for colonoscopy during the 24-month study period according to consensus
guidelines for these populations. Because recommended that individuals from HNPCC
families have colonoscopy every one to two years, all of these participants would have been
due for colonoscopy during the 24 month period and thus eligible. The recommendation for
High Risk participants is to have colonoscopy no less than every five years. Thus High Risk
participants who had a colonoscopy within the three years prior were excluded, as they
would not have been due to have another colonoscopy during the study period.
Recruitment and Randomization
Upon receiving permission to contact participants from their respective registry site, FHPP
staff at the University of Colorado Cancer Center contacted participants to recruit them into
the study (n=1,068). Of the 1,068 subjects contacted, 156 were deemed ineligible and 280
refused participation for an overall response rate of 69% (632 of 912 eligible) (Figure 1).
The 632 consenting participants, representing 533 families, completed the baseline survey
and were randomized to receive either the tailored, telephone counseling intervention
(N=322) or the general mailed intervention (N=310). Block randomization was employed to
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assure equal distribution of participants across intervention groups by recruitment site, CRC
risk level (HNPCC vs. High Risk) and by family unit to avoid experimental contamination.
Tailored, Telephone Counseling and Mailed Intervention
The components of the telephone counseling intervention have been described in detail
previously [17]. Briefly, the counseling intervention was delivered by trained interviewers
using tailored messages based on participants’ responses to the baseline survey and
motivational interviewing (MI) techniques. The intervention was grounded in several
theoretical models to promote behavior change including the Health Belief Model [26–28],
the Theory of Planned Behavior [29–31] and the Transtheoretical Model [32–34]. The
counseling intervention was conducted using computer-assisted telephone interviewing
(CATI) software of the Survey Core of the University of Colorado Cancer Center. Upon
establishing telephone contact, the interviewers began the session by eliciting the
participants’ readiness (stage of change) to have colonoscopy. Based on their response (1-
ready, 2- ready but with some reservation, or 3- not ready), the interviewer appropriately
engaged the participant in conversation about their perceived risk of CRC, risk-appropriate
screening guidelines, the pros and cons of CRC screening, and perceived barriers..
Information from the participant’s baseline assessment regarding these factors was
incorporated into the interview, which allowed the interviewers to tailor the counseling
session to focus on specific barriers and/or information gaps (ex. knowledge of screening
intervals specific to their risk level). At the end of the session, the interviewers engaged the
participants in developing an individualized action plan that was appropriate based on their
readiness to be screened. Action items ranged from talking with their family members about
the benefits of screening, to calling their provider to obtain a referral for colonoscopy. The
average intervention session lasted between 20 and 30 minutes. Following the telephone
counseling session, participants were mailed a summary of the issues discussed including
their personalized action plan that was extracted directly from the CATI software.
Participants were sent a reminder postcard in the month prior to their colonoscopy due date.
Participants randomized to the mailed intervention group were mailed a letter stating the
importance of maintaining a healthy lifestyle through exercise, diet and routine screening for
reducing risk of cancer and other chronic diseases, and were sent a Choices for Good Health
brochure, sponsored by the American Cancer Society. Participants were also encouraged to
speak with their doctors about options for CRC screening, which may be different given
their family history of CRC.
Study Outcome: Colonoscopy screening
The primary outcome of the FHPP was the prevalence of colonoscopic screening at the end
of the study period as reported on at least one of the follow-up assessments. Each
assessment asked the participant whether (and when) they had had colonoscopy since the
time of the previous survey. Participants who reported having had colonoscopy were asked
to provide consent to obtain endoscopy and pathology reports to verify screening.
Endoscopy reports were obtained for 98% of reported colonoscopies. Concordance between
self-reported colonoscopies and endoscopy reports was 100%. Thus, we included all
reported colonoscopies including the five (2%) for which we could not obtain endoscopy
reports in the analysis.
Statistical Analysis
To assess the effectiveness of randomization, we compared demographic characteristics
between intervention groups using repeated measures models to accounts for familial
clustering. These models were also used to assess any differences between groups with
respect to baseline characteristics related to CRC screening such as past screening history,
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knowledge of guidelines, intentions to screen, risk perception and barriers to screening.
McNemar’s test was used to assess change in the percent of participants who were adherent
from baseline to 24 months within study groups [35]. To account for the variability in the
length of follow-up due to participant dropout or inability to contact, we employed survival
analysis techniques to test our main hypothesis of greater adherence to colonoscopy in the
telephone counseling intervention group compared to the mailed intervention group at 24
months. Responses were censored at the time of colonoscopy or at time of the last
completed follow-up assessment. Cox proportional hazards methods [36] were used to
assess the effectiveness of the telephone intervention while adjusting for any confounding
variables identified. Regression parameters in the Cox models were estimated using a robust
sandwich covariance matrix estimate to account for the familial clustering [37]. An intent-
to-treat approach was used; thus all participants that were randomized were included in the
analysis. Possible interaction effects by risk status were assessed. The sample size was
established to enable detection of a relative difference in colonoscopy adherence of 15%
overall between intervention groups at 24 months with 80% power.
Results
A total of 632 participants were enrolled in the FHPP trial. Of the 322 participants
randomized to the telephone intervention, 306 (95%) received the intervention (16
participants could not be reached by phone within the allotted time frame per protocol), and
309 of 310 (>99%) participants in the mailed group received the mailed packet. Retention of
participants over 24-months was greater than 90% overall; 87% in the telephone and 94% in
the mailed intervention group.
Characteristics of study participants by intervention group are shown in Table 1. Twenty-
five percent of participants (N=125) met criteria for HNPCC and 75% (N=467) were
classified as High Risk. Approximately 60% of the participants were women, and the
majority were age 50 or older, Caucasian and non-Hispanic. The study population was
generally well educated, and over 90% had health insurance and a regular primary
physician. A higher percentage of participants in the mailed intervention group had at least
some college education (p=0.02) but the other demographic variables were balanced
between the two intervention groups (Table 1). There were no significant differences
between participants who consented compared to those who declined participation with
respect to gender, age, race/e ethnicity or risk level.
Despite randomization, comparison of baseline attitudes, beliefs and behaviors related to
CRC screening revealed several significant differences between the intervention groups
(Table 2). Participants in the mailed group were less likely than those in the telephone
intervention group to report barriers to screening (63% vs. 71%, p=0.048) and more likely to
be adherent with CRC screening (52% vs. 43%; p=0.04). There was also a trend toward a
higher level of knowledge of screening recommendations in the mailed group (54% vs.
47%; p=0.06). Over 70% of participants in both groups reported having at least one previous
colonoscopy, but only about 50% said they intended to have a colonoscopy within the next
24 months. Over 80% of all participants recognized that they were at elevated risk for CRC.
In total, 328 participants reported having had a colonoscopy during follow-up. The
proportion of participants who were adherent with colonoscopy at 24 months compared to
baseline was assessed. In the mailed intervention group, adherence with colonoscopy at
baseline was 52.1% and it was slightly lower (49.8%) at 24 months. In the tailored,
telephone intervention group, the prevalence of adherence was 43.2% at baseline and
increased by 11 percentage points to 54.0%. Eleven participants in the telephone and 10 in
the mailed group had colonoscopy within one month of randomization, suggesting these
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may have been scheduled prior to randomization. When stratified by risk level, we found
that the HNPCC group had greater overall adherence at 24 months compared to the High
Risk group but the absolute difference in adherence from baseline to 24 months for the
HNPCC and High Risk participants in the telephone intervention group was comparable
(about 11 percentage points) [Fig 2]. There was no increase in colonoscopy adherence from
baseline for either risk group among participants who received the mailed intervention.
Results from bivariate and multivariate analyses are shown in Table 3. In unadjusted
bivariate analysis, using an intent-to-treat approach, the tailored, telephone intervention was
associated with a 24% increase in colonoscopy adherence at 24 months (Hazard Ratio =
1.24, p=0.04). Baseline factors that were significantly associated with greater adherence
included having had a previous colonoscopy, intent to have screening, appropriate CRC risk
perception, and knowledge of risk-appropriate screening intervals. Not having a regular
doctor was associated with lower adherence as was having one or more perceived barriers to
screening. Age, gender, education, insurance status, adherence at baseline, and risk level did
not significantly predict adherence. After adjusting for significant covariates in multivariate
analysis, we found that the tailored, telephone intervention was associated with a 32%
increase in colonoscopy adherence (Hazard Ratio=1.32, p=0.01). Previous colonoscopy and
intent to have colonoscopy in the next 1–2 years were also associated with increased
adherence in the multivariate model.
Discussion
Results from the FHPP trial demonstrate that a tailored, educational and barriers counseling
intervention delivered by telephone can effectively increase adherence to colonoscopy
screening among members of high-risk CRC families. To our knowledge, this is the first
randomized trial to successfully promote colonoscopy screening in high-risk populations
that included individuals from HNPCC families. Efforts to increase both initial screening
and maintenance of screening adherence in these groups is important both because they have
a substantially increased CRC risk and they continue to demonstrate relatively low screening
adherence.
In this trial, we found that although over 80% of our participants were aware that they were
at increased CRC risk, less than 50% were adherent with recommended screening intervals
at enrollment [Table 2], which is consistent with reports from previous studies [16–20,38].
One explanation for the low adherence at baseline in our participants appears to be a lack of
knowledge of risk appropriate screening intervals. As previously reported, only 22% of
HNPCC and 52% of High Risk participants knew the recommended colonoscopy screening
interval based on their family history [17]. Given that a significant number of individuals in
the general population are predisposed to CRC due to a strong family history (about 3–5%)
[3,11] and the persistent low rates of screening in these groups, interventions that even
moderately increase screening have the potential to effectively reduce CRC morbidity and
mortality in these families, and in the population at-large.
By chance, the proportion of participants who were adherent with colonoscopy guidelines at
baseline (but as required for eligibility, due for their next screening within 24 months) was
significantly lower among participants randomized to the telephone intervention than in
those in the mailed intervention (43% vs. 52%; p=0.04). Nonetheless, our results showed an
11% absolute increase in colonoscopy screening prevalence from baseline to 24 months
(43% to 54%, p<0.004) among participants who received the telephone counseling
intervention compared to essentially no change in adherence among participants randomized
to the mailed group (52% vs. 50%, p=0.56). The multivariate analysis that accounted for the
difference in baseline adherence showed that participants who received the telephone
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intervention were 32% more likely to have colonoscopy during follow-up than those in the
mailed group.
The counseling intervention appeared to be effective in both the HNPCC and High Risk
groups. Adherence to colonoscopy upon completion of the study was somewhat higher in
the HNPCC group, which is important given their significant CRC risk, and consistent with
previous reports of higher screening prevalence in this population following genetic
education and counseling [39–42]. However, the absolute difference in adherence was
similar in both risk groups. This is encouraging, as an intervention that increases adherence
in both risk groups would have wider applicability. It can be difficult to clinically
distinguish the two risk groups without having a complete family history, which is rarely
collected in clinical practice [43–46].
There have been few randomized studies of interventions to specifically promote
colonoscopy adherence among individuals at increased risk for CRC due to family history,
and none to our knowledge, that have included persons from HNPCC families [47]. A study
by Manne et al [48] evaluated the effect of three increasingly intense behavioral
interventions on CRC screening adherence in siblings of CRC survivors: generic print
materials vs. tailored print materials vs. tailored print plus telephone counseling. Results
from this study showed that while all three interventions increased adherence, adherence
was significantly higher in each of the tailored groups compared to the generic group (25%
and 26% vs. 14%, respectively) though there was no difference in adherence between the
tailored print and tailored print plus telephone counseling groups. A second, smaller study
by Rawl et al [49] that compared the effect of two print interventions (generic vs. tailored) to
increase CRC screening among siblings and children of CRC cases similarly demonstrated
that both interventions increased adherence (21% and 14% at 12 months), but found no
difference in adherence between the tailored and generic print groups. Finally, a trial by
Glanz et al [50] tested the effect of using face-to-face risk counseling (vs. general health
counseling) to increase screening adherence among siblings of CRC cases. This intensive
intervention resulted in a net change in adherence (above the general counseling group) of
13 and 11 percentage points at 4 and 12 months respectively.
Variability across studies with respect to study population, screening outcome, intervention
intensity and mode of delivery, make it challenging to directly compare results. For FHPP,
we included participants who were adherent at baseline but who were at risk for becoming
non-adherent during the study period, whereas other studies specifically excluded these
individuals [48–49]. We also limited our outcome to colonoscopy screening, where others
have included additional CRC screening modalities [49–50]. In addition, our trial did not
include a ‘tailored-print’ arm with which to specifically compare our telephone intervention.
Nonetheless, our finding of a net change in adherence of 11 percentage points in our
telephone intervention group over that of our control group, is similar to that reported in two
previous trials [48, 50]
Taken together, with some exceptions, results from our study and others’ suggest that
tailored interventions may be more effective in promoting screening in high risk groups [47–
48, 50]. Using tailored messages is particularly relevant when addressing populations of
various risk profiles as we had in FHPP, and when attempting to promote both initial
screening as well as adherence to recommended screening intervals, which differ depending
on risk. It remains unclear as to whether print vs. telephone delivery would be equally
effective. The challenge to using a tailored approach in practice is having adequate
information about the target population a priori such as family history and known barriers,
which is often not available. One benefit of using a phone-based approach is the ability to
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assess risk, readiness and barriers in real time that can be directly translated into tailored
messages.
The FHPP study has many strengths including a prospective, randomized, controlled design,
high response and retention rates and validation of self-reported colonoscopies with
endoscopy reports. The use of two NCI-funded registries allowed the identification of
(HNPCC and High Risk) participants with well characterized and updated family history
information available. Having information about risk a priori allowed us to tailor the
intervention to appropriately address issues of CRC risk and recommended screening
intervals. Use of the CATI technology allowed the counseling intervention to be tailored in
real time and importantly, to address any persisting barriers to screening. For example, for
participants who shared that cost was an issue or that they did not feel that screening was
necessary since they did not have symptoms (two of the most common barriers), the
interviewers were able to counsel them on how to approach their provider to discuss
payment options, and were able to immediately reinforce to participants that screening is
most effective for preventing cancer before symptoms arise. These messages were included
in the action-plan that was discussed and reiterated in the follow-up letter. Finally, the use of
motivational interviewing techniques allowed the interviewers to assess and tailor messages
that were appropriate for participants’ readiness to undergo screening [17].
Our study also has some limitations. Our participants were also mostly White, affluent, had
health insurance, and higher education levels, and were all English-speaking, which may
limit generalization of our findings. Similarly, by virtue of their participation in the
registries, our participants may be different than other high-risk individuals in that they may
be more aware of their risk and the importance of screening, and therefore more motivated
to undergo screening. It is possible that participants who had colonoscopy within a month of
randomization had scheduled this prior to receiving the intervention. However, this number
was small and comparable across groups, thus it is unlikely that this significantly affected
our results. Despite the overall large sample size, the smaller size of the HNPCC subset
(n=165) limited the power to assess interactions. Finally, randomization did not result in
equal distribution of several important variables including baseline adherence to
colonoscopy. This may in part have been due to clustering of family members within
intervention groups, who may have similar screening practices. This difference attenuated
the effect of the intervention in that at 24 months the absolute screening prevalence in the
two intervention groups was similar.
In conclusion, the FHPP trial demonstrated that a relatively brief but tailored telephone-
based, education and barriers counseling intervention can increase colonoscopy screening in
persons at increased risk for CRC due to their family history. As designed, our intervention,
which was tailored in real-time by non-medical interviewers, has the potential for broad
dissemination into health-care organizations or populations (such as high risk registries) that
have the capacity to identify persons at increased risk. Though our intervention effectively
increased adherence, there remained a subset of participants who were non-adherent,
highlighting the need for continued efforts to identify strategies for improving adherence in
these high risk groups. These efforts may start with enhancing systems for identifying
persons with familial risk, ensuring that providers are aware of risk appropriate guidelines
and enlisting patient navigators to assist patients who face significant barriers to screening.
Eliciting patients’ barriers, mutually identifying ways to overcome these and developing an
action plan for taking next steps, may help to increase screening in these more resistant
populations. Analyses are underway to identify specific components from our intervention
that were most likely to increase colonoscopy adherence, which will inform the nature and
viability of broader dissemination of this intervention.
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CONSORT Flow Diagram for FHPP Trial
*CGN = Cancer Genetics Network; C-CFR = Colorectal Cancer Family Registry
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Colonoscopy adherence by risk level (High Risk (HR) vs. Hereditary Non-Polyposis Colon
Cancer (HNPCC)) and intervention group at baseline and 24 months
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Table 1
Participant Demographics by Intervention Group (N=632)
Characteristic Intervention Group





 Male 137 (43) 124 (40) 0.40
Age
 < 40 19 (6) 17 (5)
 40 – 49 88 (27) 64 (21)
 50 – 64 132 (41) 140 (45) 0.50
 65+ 83 (26) 89 (29)
Race
 African American 7 (2) 4 (1)
 Caucasian 299 (93) 290 (94) 0.62
 Other 10 (3) 13 (4)
 Missing 4 3
Ethnicity
 Hispanic 9 (3) 6 (2) 0.46
 Non-Hispanic 307 (95) 298 (96)
 Missing 6 6
Education
 Post college 59 (18) 58 (19)
 College graduate 81 (25) 94 (30)
 Some college/tech 93 (29) 102 (33) 0.02
 High school 72 (22) 49 (16)
 Less than high school 14 (4) 6 (2)
 Missing 3 1
Risk level
 HNPCC* 81 (25) 84 (27) 0.91
 High Risk 241 (75) 226 (73)
Household Income
 $70,000 or more 122 (38) 113 (36)
 $45,000 – $69,999 81 (25) 78 (25)
 $30,000 – $44,999 52 (16) 54 (17) 0.51
 $15,000 – $29,999 29 (9) 39 (13)
 < $15,000 16 (5) 12 (4)
 Missing 22 14
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Characteristic Intervention Group





 Yes 310 (96) 293 (95) 0.54
Have regular doctor
 Yes 291 (90) 291 (94) 0.11
*
Hereditary non-polyposis colorectal cancer
+
Due to rounding and missing data, percentages do not always add to 100%
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Table 2
Baseline colorectal cancer (CRC) screening behaviors, knowledge and perceived CRC risk by intervention
group (N=632)
Baseline survey question Intervention Group




Ever had colonoscopy 239 (74.2) 238 (76.8) 0.34
Adherent with CRC screening at baseline* 139 (43.2) 161 (51.9) 0.04
Intend to have colonoscopy in next 1–2 years 163 (50.6) 163 (52.6) 0.46
Knowledge of risk-appropriate screening recommendations** 151 (46.9) 166 (53.5) 0.06
Risk perception higher than others without family history 263 (81.7) 253 (81.6) 0.90
Barriers to CRC screening:
 Reported one or more barrier 228 (70.8) 196 (63.4) 0.048
 Median # of barriers (range) 2.00 (1–14) 2.00 (1–13)
*
Adherent for participants from Hereditary non-polyposis colorectal cancer (HNPCC) families = colonoscopy within past 2 years and for
participants from High Risk families =within past 5 years
**
for HNPCC reported recommendation of ‘every 1–2 years’; for High Risk reported interval no less frequent than every 5 years
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Table 3
Results from bivariate and multivariate analysis to assess the degree of screening compliance by baseline
factors and intervention group (N=632)
Subject Characteristic Bivariate Analysis Hazard Ratio
(95% C.I.) (p-value)
Multivariate Analysis† Hazard
Ratio (95% C.I.) (p-value)
Age (yrs)
 25–39 1.00 -
 40–49 0.96 (0.52, 1.76)
 50–64 1.14 (0.64, 2.05)
 65+ 1.28 (0.70, 2.33)
Male gender 0.86 (0.69, 1.08) -
Education
 No college (vs. some college or more) 1.14 (0.88, 1.48) -
No doctor 0.54 (0.30, 0.96)
(0.02)
-
No insurance 0.55 (0.27, 1.14) -
Risk group – HNPCC (vs. HR) 1.15 (0.91, 1.45) -




Adherent at baseline 1.08 (0.87, 1.34) -




Risk perception is higher than others without family history 1.73 (1.27, 2.35)
(0.0003)
-
Knowledge of risk appropriate recommendations 1.33 (1.07, 1.65)
(0.01)
-
Reported barriers to CRC screening Any barrier (yes vs. no) 0.73 (0.58, 0.92)
(0.007)
-





Adjusted for all variables with significance level of p < 0.05 in multivariate model
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